Previous studies reported elevated levels of both B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL) in serum and saliva of pSS patients compared with healthy control (62, 63). This evidence concerns the gene TNFSF13 and peeling skin syndrome.